(-)-(1R,3S)-N-Fmoc-3-Aminocyclopentanecarboxylic acid

This Fmoc-protected amino acid analog incorporates a cyclopentane ring conferring conformational restriction. The bulky scaffold supports studies of steric modulation, helix disruption, and hydrophobic packing. Researchers use it to craft rigidified peptides and explore backbone geometry. Its defined stereochemistry assists in mechanistic modeling.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
(-)-(1R,3S)-N-Fmoc-3-Aminocyclopentanecarboxylic acid(CAS 220497-67-6)

CAT No: R2159

CAS No:220497-67-6

Synonyms/Alias:rac-(1R,3S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)cyclopentane-1-carboxylic acid;220497-67-6;(-)-(1R,3S)-N-FMOC-3-AMINOCYCLOPENTANECARBOXYLIC ACID;(1R,3S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclopentanecarboxylic acid;(1R,3S)-3-(9H-fluoren-9-ylmethoxycarbonylamino)cyclopentane-1-carboxylic acid;(1R,3S)-3-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-cyclopentanecarboxylic acid;(1R,3S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)cyclopentane-1-carboxylic acid;(1R,3S)-3-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)cyclopentane-1-carboxylic acid;(1R,3S)-3-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}cyclopentane-1-carboxylic acid;rac-(1R,3S)-3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)cyclopentane-1-carboxylic acid;Fmoc-cis-NH(3)cPen-OH;(-)-(1R,3S)-N-Fmoc-3-aminocyclopentane carboxylic acid;rac-(1R,3S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)cyclopentane-1-carboxylic acid;MFCD01311758;(1R,3S)-Fmoc-3-aminocyclopentane-1 carboxylic acid;SCHEMBL7203914;DTXSID20426501;BHDMUBZVWRSQOT-KGLIPLIRSA-N;AKOS025117403;AC-7963;PS-12164;CS-0149815;EN300-650493;EN300-713797;F16413;(1s,3r)-n-fmoc-1-aminocyclopentane-3-carboxylic acid;(-)-(1S,3R)-N-Fmoc-1-Aminocyclopentane-3-carboxylic acid;(-)-(1R,3S)-N-Fmoc-3-aminocyclopentanecarboxylic acid, AldrichCPR;(1R,3S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclopentanecarboxylicacid;(1R,3S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)cyclopentanecarboxylic acid;(1R,3S)-3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]cyclopentanecarboxylic acid;957-681-0;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C21H21NO4
M.W/Mr.
351.4

rac-(1R,3S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)cyclopentane-1-carboxylic acid is a specialized amino acid derivative featuring a cyclopentane ring structure and an Fmoc (9H-fluoren-9-ylmethoxycarbonyl) protecting group on the amino function. This compound is particularly valued in the field of peptide synthesis due to its unique stereochemistry and the presence of the Fmoc group, which enables selective deprotection strategies under mild conditions. Its structural features make it suitable for introducing conformational constraints into peptide backbones, thereby enhancing the stability and biological relevance of synthetic peptides. The compound exhibits excellent solubility in organic solvents commonly used in peptide chemistry and is compatible with a wide range of coupling reagents, making it a versatile building block for advanced synthetic applications. Researchers appreciate its ability to facilitate the synthesis of peptides with non-natural amino acid residues, often leading to improved pharmacological properties and novel functionalities.

Peptide Synthesis: In peptide synthesis, rac-(1R,3S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)cyclopentane-1-carboxylic acid serves as a valuable monomer for the construction of peptides containing cyclic, conformationally restricted amino acids. The Fmoc protecting group allows for orthogonal deprotection, enabling stepwise elongation of peptide chains without compromising the integrity of sensitive functional groups. Its incorporation into peptide sequences can induce turns or helical structures, which are often desired for mimicking bioactive conformations or stabilizing secondary structures in synthetic analogs. This attribute is especially useful in the design of peptides with enhanced resistance to enzymatic degradation and improved receptor selectivity.

Drug Discovery and Development: Within drug discovery, this cyclopentane-based amino acid derivative is leveraged to generate peptide libraries that explore new chemical space. By introducing conformational constraints and non-natural side chains, it aids in the identification of lead compounds with superior binding affinities and selectivity profiles. The compound's distinctive geometry can disrupt or enhance specific molecular interactions, making it a key component in the rational design of peptide-based inhibitors, modulators, or mimetics targeting protein-protein interactions. Its utility extends to the synthesis of macrocyclic peptides, which often exhibit enhanced pharmacokinetic and pharmacodynamic properties compared to their linear counterparts.

Structural Biology Research: The use of Fmoc-cyclopentane amino acids is also prominent in structural biology, where they facilitate the synthesis of peptides and peptidomimetics for NMR or crystallographic studies. By stabilizing particular conformers, these building blocks enable researchers to probe the relationship between peptide structure and function more precisely. The resulting analogs can serve as molecular probes or standards, aiding in the elucidation of binding mechanisms, conformational dynamics, or the mapping of interaction interfaces in complex biological systems.

Materials Science: In materials science, derivatives such as rac-(1R,3S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)cyclopentane-1-carboxylic acid are utilized for the development of novel peptide-based materials. The incorporation of rigidified amino acids imparts unique mechanical and self-assembly properties to peptide polymers, facilitating the design of nanostructured materials, hydrogels, or responsive surfaces. These materials can be engineered to exhibit specific interactions with biological molecules, making them attractive for biosensing, tissue engineering, or drug delivery research.

Chemical Biology Tools: As a chemical biology tool, this Fmoc-protected cyclopentane amino acid enables the synthesis of modified peptides for probing biological pathways and molecular recognition events. Its structural rigidity and compatibility with diverse labeling strategies allow for the generation of site-specifically modified peptides, which can be used to investigate protein-ligand interactions, enzyme mechanisms, or cellular uptake processes. By facilitating the introduction of structural diversity into peptide scaffolds, it supports the development of innovative research tools for chemical biology and molecular pharmacology.

InChI
InChI=1S/C21H21NO4/c23-20(24)13-9-10-14(11-13)22-21(25)26-12-19-17-7-3-1-5-15(17)16-6-2-4-8-18(16)19/h1-8,13-14,19H,9-12H2,(H,22,25)(H,23,24)/t13-,14+/m1/s1
InChI Key
BHDMUBZVWRSQOT-KGLIPLIRSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Nucleic Acids SynthesisEpitope Mapping ServicesPeptide Modification ServicesCustom Conjugation ServicePeptide Synthesis ServicesPeptide Analysis ServicesPeptide CDMOcGMP Peptide Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers